Garvida, Catherine P.
HRN: 21-20-99 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2022
CEFUROXIME 1.5GM (VIAL)
06/11/2022
06/17/2022
IV
1.5g
Q8hours
For CS
Waiting Final Action
06/12/2022
CEFUROXIME 500MG (TAB)
06/12/2022
06/18/2022
PO
500mg
BID
S/P CS
Waiting Final Action